Pfizer Stock Target Price and Analyst Consensus

PFE -  USA Stock  

USD 52.47  1.82  3.59%

The current analyst and expert consensus on Pfizer is Buy with 4 hold recommendations. The current projected Pfizer target price consensus is 58.92 with 13 analyst opinions. One of the most common ways Pfizer Inc analysts use to provide buy-or-sell recommendation to the public are conference calls analysis and financial statements evaluations. Some experts can also talk to Pfizer vendors, executives, and/or customers. Pfizer recommendation module provides expert sentiment on the projected Pfizer Inc target price to derive its highest and lowest estimates based on target price standard deviation of 9.818. Please check Macroaxis Advice on Pfizer to cross-verify analyst projections. Unlike analyst recommendations, Macroaxis provides advice only from the perspective of investor risk tolerance and investment horizon.
  
Refresh

Pfizer Target Price Consensus

We track the performance of the top 100 financial experts across various large and mid-size financial boutiques. Pfizer target price is determined by taking all analyst projections and averaging them out. There is no one specific way to measure analysis performance other than comparing it to the past results via a very sophisticated attribution analysis. Pfizer target price projections below should be used in combination with other traditional price prediction techniques such as stock price forecasting, technical analysis, earnings estimate, and various momentum models.
Number of Opinions12
Lowered Outlook0
Raized Outlook0
Buy
Most Pfizer analysts issue ratings four times a year, at intervals of three months. Ratings are usually accompanied by a target price to helps potential investors understand Pfizer stock's fair price compared to its market value. Analysts arrive at stock ratings after researching public financial statements of Pfizer Inc, talking to its executives and customers, or listening to those companies' conference calls.
Macroaxis Advice   Exposure   Valuation

Pfizer Target Price Projection

Pfizer's current and average target prices are 52.47 and 58.92, respectively. The current price of Pfizer is the price at which Pfizer Inc is currently trading. On the other hand, Pfizer's target price is what analysts think the stock is worth or could sell for in the future. The more significant the discrepancy between the two prices, the more it stimulates investors to act.

Current Price

Pfizer Market Quote on 21st of May 2022

Low Price51.13Odds
High Price52.7Odds

52.47

Target Price

Analyst Consensus On Pfizer Target Price

Low Estimate41.0Odds
High Estimate75.0Odds
Number of Analysts13
Standard Deviation9.818

58.923

Note that most analysts generally publish their price targets in research reports on specific companies, along with recommendations for the company's stock.Although price targets are often quoted in the financial news media, there could be a delay between the publication of the latest analyst outlook on Pfizer Inc and the information provided on this page.

Pfizer Analyst Ratings

Pfizer's analyst stock recommendations are determined by taking an average estimate of all analysts we track and classifying them as Strong Buy, Buy, Hold, Strong Sell, or Sell. Ratings generally communicate what analysts sense about Pfizer stock, and they use a lot of effort and time to analyze it and arrive at a rating. That suggests that analyst recommendations are the outcome of an objective and thorough examination of Pfizer's financials, market performance, and future outlook by experienced professionals. Pfizer's historical ratings below, therefore, can serve as a valuable tool for investors.

Average Consensus Estimates

About Pfizer Target Price Projections

Pfizer's target price is an analyst's projection of its future price. Price targets can be assigned to all types of securities, from complex investment products to stocks such as Pfizer Inc and even bonds. If the target price is unavailable, it is most likely because there were not enough analyst opinions to come up with a consensus estimate. When setting a price target estimate, an analyst is trying to determine what the Stock is worth and where the price will be in a year from now. Generally, the target price of Pfizer depends on its intrinsic valuation, beta (i.e., risk over market), and overall volatility. Most analysts publish their price targets in research reports on specific companies, along with their buy, hold, or sell recommendations. Stock price targets are often quoted in the financial news media. Macroaxis uses multiple feeds to provide overall target price projection for Pfizer Inc including analysis of its current option contracts.
Pfizer's latest option contracts expiring on 2022-05-27 are carrying combined implied volatility of 27.08 with a put-to-call open interest ratio of 0.85 over 80 outstanding agreements suggesting investors are buying slightly more calls than puts on contracts expiring on 2022-05-27. The current put volume is at 2258, with calls trading at the volume of 6998. This yields a 0.32 put-to-call volume ratio. The Pfizer option chain provides detailed quote and price information for the current Pfizer Inc option contracts. It shows all of Pfizer's listed puts, calls, expiration dates, strike prices, and other pricing information.

Open Interest Against 2022-05-27 Option Contracts

Pfizer option prices can potentially be used to forecast stock returns because most option chains provide information not only about the current prices but also about the future conditions in Pfizer's lending market. For example, when Pfizer's puts are not actively trading or completely missing in the marketplace, investors can use it to internalize expected shorting costs. So if an investor is writing a put option on Pfizer, he or she must hedge the risk by shorting Pfizer stock over its option's life.
The chart above shows Pfizer's distribution of open interest by maturity on contracts that have not yet been settled. The area between the two highest points is the projection of the price at expiration. Pfizer's open interest chart also provides vital information regarding the liquidity of an option. If there is no open interest for Pfizer's option, there is no secondary market available for investors to trade.

Pfizer Maximum Pain Price across 2022-05-27 Option Contracts

Max pain usually refers to a trading concept that asserts that market manipulation can cause the market price of particular securities such as Pfizer close to expiration to expire worthless. According to most research, approximately 10% to 15% of all stock options are exercised, while about 35% expire worthlessly, with roughly 50% traded out before the expiration date. So, Max pain occurs when market makers reach a net positive position across all options at a strike price where option holders stand to lose the most money. By contrast, option sellers may reap the most after selling more options than buying, causing them to expire worthless.
Pfizer's stock options are financial instruments that give investors the right to buy or sell shares of Pfizer Inc common stock at a specified price for a given time period. Generally speaking, an option to purchase or sell Pfizer stock makes it part of the underlying stock when the option's price is tied to the movement of the underlying stock. If Pfizer's stock price goes up or down, the stock options follow.
Please check Macroaxis Advice on Pfizer to cross-verify analyst projections. Unlike analyst recommendations, Macroaxis provides advice only from the perspective of investor risk tolerance and investment horizon.

Pfizer Inc In The Money Call Balance

When Pfizer's strike price is surpassing the current stock price, the option contract against Pfizer Inc stock is said to be in the money. When it comes to buying Pfizer's options that are 'In the Money' or 'Out of the Money', the choice depends on your outlook for the underlying security, financial situation, and what you are trying to achieve.
While 'out-of-the-money' options written on Pfizer Inc are typically viewed as the more aggressive, there are potential upsides to purchasing these types of options contracts. For one, the cost to buy an 'Out of the Money' option is lower than the cost to buy an 'In the Money' option. This cost-benefit is due to the fact that at the time of the purchase, 'Out of the Money' contracts have no intrinsic value. So, while the potential for a 100% loss is more significant, the cost and risk to enter the trade are lower.

Pfizer Current Options Market Mood

Pfizer's open interest and total value indicators provide investors with the necessary information to digest the overall options buildup for its expiring contracts. In addition, it helps Pfizer Stock's traders understand whether a recent fall or rise in the market is unreasonable and if the time has come to take contrarian positions. These ratios are calculated based on options trading volumes and current open interest.

Put-to-Call Open Interest

Put-to-Call Volume

Most options investors, including buyers and sellers of Pfizer's calls and puts, are not very successful. It is estimated that an average options trader loses somewhere between 80% to 90% of the time. Pfizer's option open interest and volume spread between outstanding puts and calls are regarded by many investors as reliable indicators of the overall future market direction. Using current Pfizer's option volume and open interest to make an investment decision is considered a contrarian-sentiment measure that can be utilized in many timing strategies in both derivative and spot marketplace.

Additional Pfizer Value Projection Modules

Most investment researchers agree that the mispricing and readjustment of any Stock value happens often and is sometimes even predictable, but there is no strong theory explaining why it happens. The current price of Pfizer is a key component of Pfizer valuation and have some predictive power on the future returns of a Pfizer.
Sophisticated investors, who have witnessed many market ups and downs, frequently view the market will even out over time. This tendency of Pfizer's price to converge to an average value over time is called mean reversion. However, historically, high market prices usually discourage investors that believe in mean reversion to invest, while low prices are viewed as an opportunity to buy. Please use the tools below to analyze the current value of Pfizer in the context of predictive analytics.
Hype
Prediction
LowEstimated ValueHigh
50.3452.2454.14
Details
Intrinsic
Valuation
LowReal ValueHigh
47.2259.6761.57
Details
Naive
Forecast
LowNext ValueHigh
50.7152.6054.50
Details
Earnings
Estimates (7)
LowProjected EPSHigh
4.134.184.25
Details
Please note, it is not enough to conduct a financial or market analysis of a single entity such as Pfizer. Your research has to be compared to or analyzed against Pfizer's peers to derive any actionable benefits. When done correctly, Pfizer's competitive analysis will give you plenty of quantitative and qualitative data to validate your investment decisions or develop an entirely new strategy towards taking a position in Pfizer Inc.

Additional Pfizer Value Projection Modules

Most investment researchers agree that the mispricing and readjustment of any Stock value happens often and is sometimes even predictable, but there is no strong theory explaining why it happens. The current price of Pfizer is a key component of Pfizer valuation and have some predictive power on the future returns of a Pfizer.
Sophisticated investors, who have witnessed many market ups and downs, frequently view the market will even out over time. This tendency of Pfizer's price to converge to an average value over time is called mean reversion. However, historically, high market prices usually discourage investors that believe in mean reversion to invest, while low prices are viewed as an opportunity to buy. Please use the tools below to analyze the current value of Pfizer in the context of predictive analytics.
Hype
Prediction
LowEstimated ValueHigh
50.3452.2454.14
Details
Intrinsic
Valuation
LowReal ValueHigh
47.2259.6761.57
Details
Naive
Forecast
LowNext ValueHigh
50.7152.6054.50
Details
Earnings
Estimates (7)
LowProjected EPSHigh
4.134.184.25
Details
Please note, it is not enough to conduct a financial or market analysis of a single entity such as Pfizer. Your research has to be compared to or analyzed against Pfizer's peers to derive any actionable benefits. When done correctly, Pfizer's competitive analysis will give you plenty of quantitative and qualitative data to validate your investment decisions or develop an entirely new strategy towards taking a position in Pfizer Inc.

Currently Trending Themes

If you are a self-driven investor, you will appreciate our idea-generating investing themes. Our themes help you align your investments inspirations with your core values and are essential building blocks of your portfolios. A typical investing theme is an unweighted collection of up to 20 funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of equities with common characteristics such as industry and growth potential, volatility, or market segment.
Millennials Best
Invested few shares
Artificial Intelligence
Invested few shares
Robots And Drones
Invested over 30 shares
Please check Macroaxis Advice on Pfizer to cross-verify analyst projections. Unlike analyst recommendations, Macroaxis provides advice only from the perspective of investor risk tolerance and investment horizon. Note that the Pfizer Inc information on this page should be used as a complementary analysis to other Pfizer's statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try Idea Breakdown module to analyze constituents of all Macroaxis ideas. Macroaxis investment ideas are predefined, sector-focused investing themes.

Complementary Tools for Pfizer Stock analysis

When running Pfizer Inc price analysis, check to measure Pfizer's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Pfizer is operating at the current time. Most of Pfizer's value examination focuses on studying past and present price action to predict the probability of Pfizer's future price movements. You can analyze the entity against its peers and financial market as a whole to determine factors that move Pfizer's price. Additionally, you may evaluate how the addition of Pfizer to your portfolios can decrease your overall portfolio volatility.
Focused Opportunities
Build portfolios using our predefined set of ideas and optimize them against your investing preferences
Go
Cryptocurrency Center
Build and monitor diversified portfolio of extremely risky digital assets and cryptocurrency
Go
My Watchlist Analysis
Analyze my current watchlist and to refresh optimization strategy. Macroaxis watchlist is based on self-learning algorithm to remember stocks you like
Go
Portfolio Center
All portfolio management and optimization tools to improve performance of your portfolios
Go
Equity Analysis
Research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities
Go
Balance Of Power
Check stock momentum by analyzing Balance Of Power indicator and other technical ratios
Go
Sync Your Broker
Sync your existing holdings, watchlists, positions or portfolios from thousands of online brokerage services, banks, investment account aggregators and robo-advisors.
Go
Content Syndication
Quickly integrate customizable finance content to your own investment portal
Go
Aroon Oscillator
Analyze current equity momentum using Aroon Oscillator and other momentum ratios
Go
Bollinger Bands
Use Bollinger Bands indicator to analyze target price for a given investing horizon
Go
The data published in Pfizer's official financial statements usually reflect Pfizer's business processes, product offerings, services, and other fundamental events. But there are other numbers, ratios, or fundamental indicators derived from these statements that are easier to understand and visualize within the underlying realities that drive quantitative information of Pfizer Inc. For example, before you start analyzing numbers published by Pfizer accountants, it's critical to develop an understanding of what Pfizer's liquidity, profitability, and earnings quality are in the context of the Healthcare space in which it operates.
Please note, the presentation of Pfizer's financial position, as portrayed in its financial statements, is often influenced by management's estimates, judgments, and sometimes even manipulations. In the best case, Pfizer's management is honest, while the outside auditors are strict and uncompromising. Whatever the case, the imprecision that can be found in Pfizer's accounting process means that the reasonable investor should take a skeptical approach toward the financial statement analysis of Pfizer Inc. Please utilize our Beneish M Score to check the likelihood of Pfizer's management to manipulate its earnings.